LataMed AI is trading 10.46% down at $0.38 after no new company-specific announcement was identified for September 11, 2026.
- The latest reported catalyst was a September 9 cooperation agreement with Venezuela’s science and health ministries.
- The agreement concerns planned digital-health deployment in La Guaira but does not directly explain today’s decline.
- Broader markets are rising, so the move is not aligned with the provided market-wide rally.